| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.14 | 0.6 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |